ONXX Financial Facts

Selling, general and administrative: 72.55M
Loss from operations: -28.47M
See Full Income Statement

Intangible assets - in-process research and development: 171.5M
Marketable securities, current: 294.16M
See Full Balance Sheet

Earnings History for Onyx Pharmaceuticals Inc. (ONXX)

  |   Expand Research on ONXX
Next EPS Date 7/31/13 *Est. EPS Growth Rate +72.1% *Last Qtr.
Average EPS % Beat Rate +30.2% Revenue Growth Rate +102.1% *Last Qtr.
Average % Move 1-Wk after EPS +2.3%    
Date  Qtr EPS Cons. Surprise Revs Cons. Estimize EPS/Revs Gd. % Since Details
11/1/12 Q312 -$0.79-$0.90 +$0.11$89.51M$80.02M N/A / N/A N/A +19% Details
5/2/12 Q112 -$0.68-$0.55 -$0.13$72M$69.82M N/A / N/A N/A +111.6% Details
8/1/12 Q212 -$0.68-$0.66 -$0.02$72.7M$72.07M N/A / N/A N/A +30.2% Details
8/3/11 Q211 -$0.43-$0.13 -$0.30$67.96M$74.72M N/A / N/A N/A +213.6% Details
2/21/13 Q412 -$0.36-$0.75 +$0.39$127.9M$113.17M N/A / N/A N/A +36% Details
11/2/11 Q311 -$0.31-$0.19 -$0.12$75.04M$80.38M N/A / N/A N/A +142.3% Details
2/23/11 Q410 -$0.28-$0.02 -$0.26N/A$67.22M N/A / N/A N/A +176.2% Details
5/7/13 Q113 -$0.19-$0.47 +$0.28$145.5M$134.36M N/A / N/A N/A +5.8% Details
Like ONXX Earnings? Also take a look at LGND, GSK, CELG, PURE

ONXX Earnings News